Andrew Barnell was featured on the New York Stock Exchange’s NYSE Floor Talk, sharing Geneoscopy’s mission from the NYSE floor. During the insightful interview, Andrew discussed how we are transforming gastrointestinal health through our FDA-approved at-home test, ColoSense. He highlighted our commitment to removing barriers to screening—like the “fear and discomfort” often associated with traditional methods—by offering a simple, high-sensitivity solution that requires no bowel prep…
